Olympus to pay US$646m for bribing hospitals, doctors
[WASHINGTON] The US unit of Japan's camera and hospital equipment maker Olympus agreed to pay US$646 million Tuesday to settle charges it gave hospitals and doctors kickbacks to buy its endoscopes.
To boost its sales, Olympus Corp of the Americas gave free trips to Japan to doctors who got their hospital to buy Olympus equipment; it gave a financial grant to another hospital in exchange for a sale; and it blocked a grant to another hospital until it agreed to buy Olympus equipment, the US Justice Department said.
A unit of OCA engaged in similar behaviour in Latin America as well, the department said.
It said the kickback practices between 2006 and 2011 helped the company obtain more than US$600 million in sales and US$230 million in profits.
The company was charged in a criminal complaint Tuesday with violating anti-kickback laws and the US Foreign Corrupt Practices Act (FCPA).
But prosecution on the charges was deferred as the company cooperated in the investigation and agreed to the fines and remedial actions.
The fines included a US$312.4 million criminal penalty and US$310.8 million to settle civil claims. An additional US$22.8 million fine addresses the FCPA charges.
"The Department of Justice has longstanding concerns about improper financial relationships between medical device manufacturers and the health care providers who prescribe or use their products," said Principal Deputy Assistant Attorney General Benjamin Mizer in a statement.
"Such relationships can improperly influence a provider's judgment about a patient's health care needs, result in the use of inferior or overpriced equipment, and drive up health care costs for everybody." In a statement, OCA said it "acknowledges the Company's responsibility for the past conduct, which does not represent the values of Olympus or its employees." "Olympus is committed to complying with all laws and regulations and to adhering to our own rigorous Code of Conduct."
AFP
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO